Designing Multi-Target Drugs
Chapter 13: Identification and Optimization of Dual PI3K/mTOR Inhibitors
-
Published:28 Mar 2012
-
Special Collection: 2012 ebook collection , 2011-2015 industrial and pharmaceutical chemistry subject collectionSeries: Drug Discovery
Andreas Karlsson, Carlos García-Echeverría, 2012. "Identification and Optimization of Dual PI3K/mTOR Inhibitors", Designing Multi-Target Drugs, J. Richard Morphy, C John Harris
Download citation file:
The constitutive activation of the PI3K/mTOR pathway in cancer cells has been validated by epidemiological and experimental studies as an essential step towards the initiation and maintenance of human tumors. A number of intracellular components of this pathway have been targeted for anti-cancer drug discovery activities leading to the current panoply of clinical trials of PI3K/mTOR pathway modulators. The progress in the identification and development of early polypharmacology-based inhibitors that concomitantly target PI3K and mTOR is presented and discussed in this chapter.
